Floatz logo

WARFARIN

Strokes Thrombotic

Wuhan Asia Heart HospitalSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Strokes Thrombotic cohort.

Asset / SponsorPhaseRating
MELATONIN
Hospital San Carlos, Madrid
Phase 4BB
mlc1501
Moleac Pte Ltd.
Phase 2/3BB
DABIGATRAN ETEXILATE
Wuhan Asia Heart Hospital
D

Same molecule, other indications

WARFARIN is also rated in:

venous thromboembolismDormant
A
Indicative ·
81 / 100
View asset →
atrial fibrillationDormant
BBB
Indicative ·
77 / 100
View asset →
hemorrhagic diseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →